PATENT AND LICENSE SECURITY AGREEMENTPatent and License Security Agreement • December 24th, 2008 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 24th, 2008 Company Industry JurisdictionThis PATENT AND LICENSE SECURITY AGREEMENT (this “Agreement”), dated as of December 22, 2008, is by and between GTC BIOTHERAPEUTICS, INC. (“Grantor”) and LFB BIOTECHNOLOGIES S.A.S.U. (“Grantee”).
TRADEMARK AND LICENSE SECURITY AGREEMENTTrademark and License Security Agreement • December 24th, 2008 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledDecember 24th, 2008 Company Industry JurisdictionThis TRADEMARK AND LICENSE SECURITY AGREEMENT (this “Agreement”), dated as of December 22, 2008, is by and between GTC BIOTHERAPEUTICS, INC. (“Grantor”) and GENERAL ELECTRIC CAPITAL CORPORATION (“Grantee”).
SECURITY AGREEMENTSecurity Agreement • December 24th, 2008 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledDecember 24th, 2008 Company IndustryTHIS SECURITY AGREEMENT (this “Agreement”) dated as of the 22nd day of December, 2008, from GTC BIOTHERAPEUTICS, INC. (“Debtor”) in favor of LFB BIOTECHNOLOGIES S.A.S.U. (together with its successors and assigns, if any, “Secured Party”). Secured Party has an office at 3, avenue des Tropiques, Les Ulis, Courtaboeuf, France. Debtor is a corporation organized and existing under the laws of the state of Massachusetts (the “State”). Debtor’s mailing address and chief place of business is 175 Crossing Blvd., Framingham, MA 01702.
GTC BIOTHERAPEUTICS, INC. AND AMERICAN STOCK TRANSFER AND TRUST COMPANY AS RIGHTS AGENT AMENDMENT No. 2 TO SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • December 24th, 2008 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledDecember 24th, 2008 Company Industry JurisdictionThis SECOND AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT dated as of December 22, 2008 (the “Amendment”) is between GTC Biotherapeutics, Inc., a Massachusetts corporation formerly known as Genzyme Transgenics Corporation (the “Company”), and American Stock Transfer and Trust Company, a banking organization organized under the laws of New York, as Rights Agent (the “Rights Agent”).
CONSENT AND AMENDMENT NO. 3 TO AMENDED AND RESTATED MASTER SECURITY AGREEMENTMaster Security Agreement • December 24th, 2008 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledDecember 24th, 2008 Company Industry JurisdictionTHIS CONSENT AND AMENDMENT NO. 3 TO AMENDED AND RESTATED MASTER SECURITY AGREEMENT (this “Amendment”) dated as of the 22nd day of December, 2008, by and between GTC BIOTHERAPEUTICS, INC. (“Debtor”) and GENERAL ELECTRIC CAPITAL CORPORATION (together with its successors and assigns, if any, “Secured Party”).